Answers are grounded in this paper and cite their sources.
Adult hemophagocytic lymphohistiocytosis (HLH) is diagnostically challenging due to clinical overlap with sepsis, autoimmune disorders, and malignancy‐associated hyperinflammation, and existing criteria were developed primarily in pediatric cohorts. We evaluated peripheral blood CD8 + T‐cell immunophenotyping as a diagnostic adjunct in adults with suspected HLH, compared against an adapted Fardet‐style HScore. This single‐center observational cohort study enrolled 106 consecutive adults with cytopenias and hyperferritinemia undergoing bone marrow examination. Patients were classified as HLH ( n = 50) or non‐HLH ( n = 56) by revised HLH‐2004 criteria with expert adjudication. Multiparametric flow cytometry quantified single‐positive CD8 + CD38 + and CD8 + HLA‐DR + and dual‐positive CD8 + CD38 + HLA‐DR + subsets. Diagnostic performance was assessed by ROC analysis with Youden‐index‐derived cut‐offs. CD8 + CD38 + HLA‐DR + was the strongest flow‐cytometric marker (AUC 0.824). At the Youden‐optimal threshold (>16.71% of parent CD8 + T cells), sensitivity was 78% and specificity 81%; at an exploratory 22.69% threshold (same parent CD8 + subset), sensitivity was 64.0% and specificity 87.5%. Single‐positive CD8 + CD38 + (AUC 0.564) and CD8 + HLA‐DR + (AUC 0.427) subsets did not discriminate. The adapted HScore achieved an AUC of 0.970; at a threshold of >196, sensitivity was 94.0% and specificity was 87.5%. The adapted HScore provided the strongest clinicobiochemical framework. CD8 + CD38 + HLA‐DR + was the best‐performing flow‐cytometric adjunct, offering high specificity for rule‐in in gray‐zone adult HLH. An integrated strategy combining clinical scoring with immune activation profiling is recommended.
No takes yet. Share an insight, caveat, or question.
Mondal et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: